Jafron Biomedical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 34.37%

Jafron Biomedical Co Ltd asset resilience ratio. Jafron Biomedical Co Ltd (300529) has an Asset Resilience Ratio of 34.37% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Jafron Biomedical Co Ltd to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.79 Billion

≈ $261.32 Million USD Cash + Short-term Investments

Total Assets

CN¥5.20 Billion

≈ $760.31 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Jafron Biomedical Co Ltd (2016–2025)

Asset resilience ratio of Jafron Biomedical Co Ltd from 2016 to 2025. This chart shows how Jafron Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Read how much debt does Jafron Biomedical Co Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Jafron Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Jafron Biomedical Co Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.79 Billion	34.37%
Total Liquid Assets	CN¥1.79 Billion	34.37%

Asset Resilience Insights

Very High Liquidity: Jafron Biomedical Co Ltd maintains exceptional liquid asset reserves at 34.37% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jafron Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jafron Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Shenzhen New Industries Biomedical SHE:300832	Medical Devices	9.95%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
BMC Medical Co. Ltd. A SHE:301367	Medical Devices	44.96%
Emvision Medical Devices Ltd AU:EMV	Medical Devices	0.06%
Hironic Co. Ltd KQ:149980	Medical Devices	17.42%
DRGEM Corporation KQ:263690	Medical Devices	2.12%
Oncosil Medical Ltd AU:OSL	Medical Devices	0.00%
Adherium Ltd AU:ADR	Medical Devices	15.45%

Jafron Biomedical Co Ltd Asset Resilience Ratio by Year (2016–2025)

Jafron Biomedical Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Jafron Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.00%	CN¥61.82K ≈ $9.05K	CN¥5.41 Billion ≈ $791.50 Million	-11.02pp
2024-12-31	11.02%	CN¥593.07 Million ≈ $86.79 Million	CN¥5.38 Billion ≈ $787.77 Million	+7.90pp
2021-12-31	3.12%	CN¥150.01 Million ≈ $21.95 Million	CN¥4.81 Billion ≈ $703.87 Million	-4.57pp
2016-12-31	7.69%	CN¥100.00 Million ≈ $14.63 Million	CN¥1.30 Billion ≈ $190.21 Million	--

pp = percentage points

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$2.19 Billion

CN¥14.99 Billion CNY

Market Cap Rank

#5624 Global

#969 in China

Share Price

CN¥18.77

Change (1 day)

-0.74%

52-Week Range

CN¥14.85 - CN¥20.96

All Time High

CN¥96.12